CD4 and cancer: Interestingly, Gls1 deletion alone led to an immune suppressive tumor microenvironment facilitated by increased cancer-associated fibroblasts (CAF) & IL2_STAT5 signaling while simultaneously decreasing inflammatory & activated CD4 T cell responses (Fig. 6d).